Seres Therapeutics (NASDAQ: MCRB) reported Q2 EPS of ($0.69), versus ($0.70) reported last year. Revenue for the quarter came in at $3.01 million, versus $3 million reported last year.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.